Altimmune, Inc. (ALT) Tops Q3 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Boeing lands two U.S. defense contracts worth over $711M
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c